| | | | | | | RegenMD | | | | | | | | | | | | | | | | And in its place stands the burgeoning field of regenerative medicine, or tissue engineering, which seeks to harnesses the body's own healing powers. Tissue engineering, a field stitched together from biology, chemistry, engineering, and medicine, ... See all stories on this topic » | | | | | | | | | | | | | | | | | | | | | Menlo Park-based Geron (NASDAQ:GERN) said the funding will support the clinical development of GRNOPC1, Geron's cell therapy containing oligodendrocyte progenitor cells derived from human embryonic stem cells. The therapy is in a Phase 1 trial in ... See all stories on this topic » | | | | | | | | | | | | | | | | | | | | | ThermoGenesis (NASDAQ:KOOL) is a regenerative medicine company focused on the development and commercialization of products and devices for the collection, processing and storage of adult stem cells derived from the bone marrow and cord blood sources, ... See all stories on this topic » | | | | | | | | | | | | | | | | | | | | | The California Institute for Regenerative Medicine (CIRM) just reached a breakthrough $37.7 million dollar approval Wednesday when its governing board voted on whether to fund a clinical trial involving a therapy derived from stem cells. ... See all stories on this topic » | | | | | | | | | | | | | | | | | | | | | By day, Girl Talk is Gregg Gillis, a huge Pittsburgh sports fan and former biomedical engineer who got a degree with an emphasis on tissue engineering, then had to quit his day job when his music career took off. Gillis will be talking Pittsburgh ... See all stories on this topic » | ESPN | | | | | | | | | | | | | | | | | | | | | | Advanced Cell Technology, Inc. is a biotechnology company focused on developing and commercializing human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintains a ... See all stories on this topic » | | | | | | | | | | | | | | | | | | | | | EAST NORRITON, Pa., May 4, 2011 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Thursday, May 12, 2011 at 8:30 am EDT to provide a business update ... See all stories on this topic » | | | | | | | | | | | | | | | | | | | | | MEDICAL devices company Tissue Regenix said it is set to become a major player in regenerative medicine despite posting a loss last year. The York-based company, which began trading on AIM last year following its reverse takeover of Oxeco, ... See all stories on this topic » | | | | | | | | | | | | | |
No comments:
Post a Comment